NanoHive Medical
United States
- Woburn, Massachusetts
- 06/08/2024
- Series C
- $7,000,000
NanoHive Medical (formerly HD LifeSciences) created the proprietary, biomimetic Soft Titanium technology, which clearly distinguishes their products in the $1.9B spinal interbody fusion device market. The Hiveâ„¢ portfolio of interbody fusion devices provides surgeons and their patients with the ideal features that lead to consistently strong fusion constructs and efficacious clinical experiences.
- Industry Medical Equipment Manufacturing
- Website https://nanohive.com/
- LinkedIn https://www.linkedin.com/company/nanohivemedical/
Related People
Patrick O.Founder
United States -
Greater Boston
Medical Device and Biosurgery executive leader with over 25 years of consistently successful experience at pre-commercial and commercial stages companies. Success in the medical device, orthobiologics, and biomaterials industries with technologies in the orthopedic, spine, neurosurgery, sports medicine, interventional radiology markets. Extensive team-building, executive management, strategy development, sales and marketing management, strategic partnership development, distribution channel development, Board management, start-up, turn around, and fund raising (over $90M) experience.
Vector 👻 | $10,000,000 | (May 14, 2026)
Avant Genomics | $3,000,000 | (May 14, 2026)
Data Mission | $1,000,000 | (May 14, 2026)
Origin Lab | $8,000,000 | (May 14, 2026)
CREATE Medicines | $122,000,000 | (May 14, 2026)
Synthetic | $10,000,000 | (May 14, 2026)
SwishX | $2,200,000 | (May 14, 2026)
Dolfin | $2,460,580 | (May 14, 2026)
Urologic Health | $11,000,000 | (May 14, 2026)
Saile Medical (Saile App) | $2,200,000 | (May 14, 2026)
4AM | $4,000,000 | (May 13, 2026)
Adfin | $18,000,000 | (May 13, 2026)